Schuster, S., Nadjar, A., Guo, J. T., Li, Q., Ittrich, C., Hengerer, B., & Bezard, E. (2008). The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of l-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease. J Neurosci.

Schuster, Stefan, Agnès Nadjar, Jun Tang Guo, Qin Li, Carina Ittrich, Bastian Hengerer, och Erwan Bezard. "The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease." J Neurosci 2008.

Schuster, Stefan, et al. "The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease." J Neurosci 2008.